Canada′s First Universal Varicella Immunization Program: Lessons from Prince Edward Island
Open Access
- 1 January 2003
- journal article
- research article
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 14 (1) , 41-44
- https://doi.org/10.1155/2003/904351
Abstract
A live attenuated varicella vaccine was licensed in Canada in December 1998. The first universal varicella immunization program in Canada was initiated in Prince Edward Island in 2000. Students in grades one to six without a history of varicella were offered the vaccine, administered by Public Health Nurses, in school clinics during February and March 2000. The acceptance rate ranged from 29.1% of all grade one students to 9.8% of all grade six students; overall, 18.8% of students received the vaccine. A universal program for children 12 months of age was introduced on April 1, 2000 and catch‐up clinics for those between 12 months of age and those in grade one were introduced in June 2000. Repeated media announcements and the cooperation of staff in schools and daycare facilities assisted in informing parents about the availability of the vaccine. Vaccine‐ associated adverse events have been uncommon and the vaccine has been well accepted.Keywords
This publication has 12 references indexed in Scilit:
- Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. An Advisory Committee Statement (ACS).2008
- The postmarketing safety profile of varicella vaccineVaccine, 2000
- Towards universal childhood immunization against chickenpox?Paediatrics & Child Health, 2000
- American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update.2000
- Varicella Susceptibility in a Canadian PopulationCanadian Journal of Infectious Diseases and Medical Microbiology, 2000
- Postmarketing evaluation of the safety and effectiveness of varicella vaccineThe Pediatric Infectious Disease Journal, 1999
- Cost of Chickenpox in Canada: Part I. Cost of Uncomplicated CasesPublished by American Academy of Pediatrics (AAP) ,1999
- Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R®II, VARIVAX® and TETRAMUNE® in healthy children vs. concomitant injections of M-M-R®II and TETRAMUNE® followed six weeks later by VARIVAX®The Pediatric Infectious Disease Journal, 1998
- A Long-term Prospective Study of Varicella Vaccine in Healthy ChildrenPediatrics, 1997
- Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant motherThe Journal of Pediatrics, 1997